Welcome to our dedicated page for CURALEAF HLDGS news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on CURALEAF HLDGS stock.
Curaleaf Holdings, Inc. (CURLF) is a prominent international provider of consumer cannabis products, known for its mission to enhance lives by sharing and celebrating the power of the plant. It operates under various brands like Curaleaf, Select, Grassroots, JAMS, Find, and Zero Proof in the medical and adult-use markets. With operations in over 15 countries globally, Curaleaf focuses on quality, expertise, and accessibility in the cannabis industry.
Recently, Curaleaf announced a strategic acquisition of Northern Green Canada, a licensed Canadian cannabis producer with a focus on international market expansion. This move aligns with Curaleaf's vision of becoming a global cannabis company with a strong presence in North America, Europe, and Australasia. The acquisition of NGC provides Curaleaf with EU-GMP certification, enabling the company to strengthen its supply chain, improve margins, and extend its global footprint.
Under the leadership of Boris Jordan, Executive Chairman, and Matt Darin, CEO, Curaleaf continues to drive growth and innovation within the cannabis space. The company's commitment to delivering high-quality products and patient access remains a top priority in evolving markets and regulatory environments.
Curaleaf (CSE: CURA / OTCQX: CURLF), a leading cannabis provider, has partnered with Repsly, a retail technology platform, to enhance its wholesale operations across the U.S. This collaboration, announced on February 2, 2022, aims to leverage Repsly's CRM solutions, retail execution support, and business analytics. With 125 dispensaries in 23 states, Curaleaf will utilize Repsly's Insights Dashboard to improve sales performance and adapt strategies based on real-time data. The rollout of the Repsly platform will commence in February 2022.
Curaleaf Holdings will report its financial results for Q4 and fiscal year 2021 on March 3, 2022, after market close. The management team will host a conference call at 5:00 p.m. ET to discuss operational and financial highlights, followed by a Q&A session. The call can be accessed via U.S. and international dial-in numbers and will also be available for replay until March 10, 2022. Curaleaf operates in 23 U.S. states with 125 dispensaries and is recognized as a leading international cannabis provider.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) expands its retail footprint by opening two new dispensaries in Pennsylvania, increasing its statewide presence to 14 locations and total U.S. locations to 125. The Greensburg dispensary celebrated its Grand Opening on January 20, while Wayne's Grand Opening is scheduled for January 27. The new locations will offer a variety of cannabis products and support medical research for over 681,000 registered patients in the state. The company aims to enhance patient care through research-based education and product accessibility.
Curaleaf Holdings has completed its acquisition of Bloom Dispensaries for approximately US$211 million, expanding its presence in Arizona to 13 dispensaries and 121 nationwide. Bloom, a profitable operator with 2021 revenue of about US$66 million and over 40% EBITDA margins, enhances Curaleaf's capacity in Arizona's US$1.4 billion market. The acquisition is expected to be immediately accretive to Curaleaf's adjusted EBITDA margins, supporting its growth strategy in a region with strong long-term potential.
Curaleaf Holdings, a leading cannabis company, is expanding its retail presence by opening two new dispensaries in Florida by the end of January 2022. This will increase its total dispensaries to 44 in Florida and 119 nationwide. The new locations are Curaleaf Tampa Bay Mabry, which opened on January 15, and Curaleaf Largo, expected to open later this month. Curaleaf has significantly increased its market share in Florida, reaching 15%. The company continues to innovate with new products, enhancing access to its offerings.
Curaleaf Holdings (CSE: CURA / OTCQX: CURLF) will report its fourth quarter and fiscal year results for 2021 after market close on March 7, 2022. A conference call will follow at 5:00 p.m. ET to discuss operational and financial highlights. Curaleaf operates in 23 states with 117 dispensaries and is the largest vertically integrated cannabis company in Europe. The company is focused on providing high-quality cannabis consumer products and improving lives through its offerings.
Curaleaf Holdings announced participation in key investor conferences in January 2022. Notable events include the ICR Conference on January 10, featuring Executive Vice Chairman Joseph Lusardi, and the 24th Annual Needham Virtual Growth Conference on January 12, with Executive Chairman Boris Jordan.
Additionally, CEO Joe Bayern will participate in the ATB's 10th Annual Institutional Conference on January 13. Curaleaf operates 117 dispensaries and 25 cultivation sites across 23 U.S. states, and is recognized as a major player in the cannabis sector, aiming to enhance consumer confidence and clarity around cannabis.
Curaleaf Holdings, Inc. announced the appointment of Matt Darin as President, effective immediately, to enhance organizational efficiency during a period of significant growth. Darin, the former COO of Grassroots Cannabis, has extensive industry experience and will report to CEO Joseph Bayern. The company is undergoing strategic acquisitions including Los Suenos Farms and Bloom Dispensaries. Additionally, COO Neil Davidson is retiring effective January 3, 2022, but will assist during the transition until March 31, 2022. Curaleaf continues to expand its operations across 23 states.
Curaleaf has announced its acquisition of Bloom Dispensaries for approximately US$211 million, enhancing its operational presence in Arizona. This cash transaction, set to close in January 2022, will increase Curaleaf's Arizona dispensary count to 16 and expand its footprint to 128 retail locations nationwide.
The acquisition is projected to be immediately accretive to Curaleaf's adjusted EBITDA margins, with Bloom generating 2021 revenues of around US$66 million and boasting more than 40% EBITDA margins.
Curaleaf announced its tenth dispensary in Arizona, acquiring Natural Remedy Patient Center for approximately US$13 million. This cash and stock transaction will close in January 2022, increasing Curaleaf's retail footprint to 118 dispensaries across the U.S. The existing Safford location will be relocated to a new, flagship 9,000 square foot dispensary in Scottsdale, enhancing visibility at a high-traffic site. The company emphasizes its strategy to expand its U.S. presence through acquisitions and organic growth.
FAQ
What is the current stock price of CURALEAF HLDGS (CURLF)?
What is the market cap of CURALEAF HLDGS (CURLF)?
What is Curaleaf Holdings, Inc. known for?
Who are the key leaders at Curaleaf?
What recent acquisition has Curaleaf made?
Where does Curaleaf operate?
